LD59 is an emergency bill that would classify tianeptine as a Schedule W controlled drug in Maine. The bill amends the state’s controlled substances scheduling provisions to add “Tianeptine” to the list of prohibited substances, making its possession, distribution, and related conduct subject to the penalties and enforcement framework that applies to Schedule W drugs. The bill states that tianeptine is highly addictive and associated with overdose deaths, and it invokes the emergency clause to make the change effective immediately upon approval rather than waiting for the normal post-adjournment effective date.
In practical terms, the bill would expand Maine’s drug control laws by placing tianeptine alongside other scheduled substances, including PMEA and other drugs covered under the same statutory section. This would affect consumers, retailers, and any entities involved in the sale or distribution of tianeptine, including products marketed as supplements or wellness aids if they contain the substance. It would also give law enforcement and prosecutors a clearer statutory basis to treat tianeptine as an illicit controlled substance under state law.
The general sentiment reflected in the bill text is strongly supportive of prohibition, emphasizing public health and safety concerns, addiction risk, and overdose deaths. The emergency designation signals that the sponsor and supporters viewed the issue as urgent and requiring immediate legislative action. However, the voting history shows the bill encountered substantial resistance, with a motion to accept an “ought not to pass” report passing narrowly in one vote and a related vote also close, indicating divided views among legislators.
The main point of contention appears to be whether tianeptine should be treated as a controlled drug through immediate scheduling, versus leaving it unbanned or addressing it through other regulatory or public health measures. Supporters appear focused on preventing addiction and overdose, while opponents likely questioned the need for an emergency ban, the scope of criminalization, or whether the substance should be handled differently. The close vote totals suggest the bill was controversial and not broadly consensus-driven.
Impact
LD59 would amend Maine’s controlled substances schedule to add tianeptine as a Schedule W drug, thereby subjecting it to the state’s criminal and regulatory restrictions for controlled substances. This would affect state enforcement, criminal penalties, and any businesses or individuals handling tianeptine, including potential retail and online sellers. The emergency clause would make the change effective immediately upon enactment.
Sentiment
The bill is framed in strongly public-safety-oriented terms, with supporters emphasizing addiction and overdose risks and treating the issue as an emergency. At the same time, the voting history indicates the proposal was divisive and faced meaningful opposition, with close roll-call results suggesting the Legislature was split on whether an immediate ban was the right response.
Contention
The central disagreement is over whether tianeptine should be banned and scheduled immediately as a controlled substance. Supporters argue the drug is highly addictive and linked to overdose deaths, justifying emergency action. Opponents appear to have favored an “ought not to pass” position, suggesting concern about the necessity, scope, or policy approach of criminalizing the substance rather than using a different regulatory or public health strategy.